<DOC>
	<DOCNO>NCT02648841</DOCNO>
	<brief_summary>The purpose study explore role adjuvant chemo-radiotherapy patient local advance gastric cancer .</brief_summary>
	<brief_title>A Randomized Phase III Study Adjuvant Chemotherapy With Without Chemo-radiotherapy Patients With Local Advanced Gastric Cancer After D2 Resection .</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Gastric cancer ; D2 R0 resection ; Pathologically confirm stage anyT , N+ , M0 ( AJCC Cancer Staging ) ; Karnofsky performance score ( KPS ) &gt; = 70 Eastern Cooperative Oncology Group ( ECOG ) score 01 ; Adequate blood count : White blood cell count ≥3.5 x 109/L Haemoglobin level ≥100g/L Platelet count ≥100 x 109/L Creatinine level ≤1.0× upper normal limit（UNL） Urea nitrogen level ≤1.0× upper normal limit（UNL） Alanine aminotransferase ( ALT ) ≤1.5× upper normal limit（UNL） Aspartate aminotransferase ( AST ) ≤1.5× upper normal limit（UNL） Alkaline phosphatase ( ALP ) ≤1.5× upper normal limit（UNL） Total bilirubin ( TBIL ) ≤1.5× upper normal limit（UNL） No allergic history 5Fu Platinum drug ; No history chemotherapy anticancer therapy ; Informed consent sign . GEJ adenocarcinoma Concomitant malignancy ; ( except basocellular carcinoma insitu cervical carcinoma ) Allergic Fluorouracil Platinum drug ; Concurrent uncontrolled medical condition ; Known malabsorption syndrome lack physical integrity upper gastrointestinal tract ; Severe postoperative complication anastomotic leakage , etc . ; Symptoms history peripheral neuropathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>adjuvant chemo-radiotherapy</keyword>
</DOC>